Clinical Grand Rounds
ADVANCED RECOVERY INSTITUTE | CLINICAL GRAND ROUNDS
Leading Experts Addressing Timely Topics
Our monthly program brings together recognized experts in the mental health and addiction fields to share insights and best practices from their research and clinical experience.
The virtual series runs every third Thursday (unless otherwise noted) of the month from 12-1:30pm. These presentations are free and open to the public ($10 if requiring CEUs, free CEUs for Root staff). If interested, please register below for each session.
Synopsis & Objectives:
This presentation will delve into understanding the development, treatment, and prevention of depression in senior and geriatric patients in various care settings.
Synopsis & Objectives:
The Analog Antidote explores what we lost, what we gained, and what we must protect as addictive technology reshapes human connection, attention, and wellbeing. Drawing on decades inside the tech industry and years researching its social costs, John Murphy offers mental health professionals a clear-eyed framework for understanding digital harm — and practical strategies for helping clients stay grounded in an increasingly ungrounded world.
Objectives: Participants will be able to (1) identify the psychological mechanisms behind addictive technology design; (2) articulate the documented costs of chronic digital immersion on attention, relationships, and identity; and (3) apply at least two analog-grounded strategies when working with clients navigating technology-related stress or disconnection.
Synopsis & Objectives:
Coming soon!
Synopsis and Objectives:
This session will explore the context as a determinant of behavior in addiction and recovery. Research suggests that the context, such as the social environment and availability of robust alternative reinforcers, impacts the etiology, maintenance, and recovery from addictive behaviors, yet such factors are often underemphasized in treatment and prevention models. This session will outline contextual models of addiction and recovery, review empirical evidence supporting the role of context, and outline potential benefits of a contextual model at the level of the individual and society in the areas of science, clinical practice, and policy.
Synopsis & Objectives:
We will discuss the latest updates to Contingency Management Interventions in the treatment of substance use disorders, including policy developments, implementation fidelity, and technology adaptations.
Synopsis & Objectives:
Attendees will be able to: Review medications 1) approved for treating alcohol use disorder, 2) used off-label for that purpose, and 3) in active development for that indication.
Synopsis & Objectives:
This talk will describe evidence supporting use of a real-time amygdala targeted fMRI neurofeedback protocol focused on positive memory recall for the treatment of mood disorders and suicide risk, both as a standalone treatment and supplement to CBT/DBT therapy. By the end of the presentation, participants will be able to provide a basic description of real-time fMRI neurofeedback and explain why targeting 1) the amygdala and 2) positive memory recall may help to reduce symptoms of depression and suicide risk.
Synopsis & Objectives:
Coming soon!
Synopsis & Objective:
This presentation covers key risk factors of psychotic disorders in young adults and how these patients may look at initial presentation. The role of coordinated specialty care is highlighted and practical advice is provided for when such care is not an option. Important sticking points in treatment of first episode psychosis are also covered.
Synopsis and objectives:
Synopsis
Cannabis is the most commonly used secondary substance among patients in opioid treatment programs, and staff frequently encounter patients who believe cannabis is harmless, even helpful, for their recovery. This presentation examines what the evidence actually shows about cannabis use among patients receiving methadone for opioid use disorder: its effects on treatment retention and opioid use outcomes, the risk of cannabis use disorder in this population, methadone-cannabis interactions, and practical strategies OTP staff can use to screen for, counsel on, and address cannabis use without jeopardizing the therapeutic relationship or treatment engagement.
Learning Objectives
Upon completion of this presentation, participants will be able to:
1. Evaluate the current evidence on how concurrent cannabis use affects methadone treatment outcomes including treatment retention, opioid use, and overdose risk.
2. Recognize cannabis use disorder in OTP patients and understand why ASAM guidelines recommend against requiring cannabis abstinence as a condition of continued methadone treatment.
3. Apply screening, brief intervention, and harm reduction strategies for cannabis use that are appropriate for the OTP setting and consistent with a patient-centered, nonpunitive approach.
Synopsis and Objectives:
Measurement-based care is a clinical framework where providers routinely and systematically collect and review patient data to track progress and guide treatment decisions. This presentation will describe how measurement-based care can be used in substance use disorder treatment and describe challenges and opportunities in implementing it into routine care.
Synopsis and Objectives:
Coming soon!
Synopsis & Objectives:
This presentation will delve into understanding the development, treatment, and prevention of depression in senior and geriatric patients in various care settings.
